Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2025-12-24 @ 3:51 PM
NCT ID:
NCT05366192
Eligibility Criteria:
Inclusion Criteria:
* 1.Understand the present study/Agree and sign informed consent.
* 2.Age is between 18 and 75 at the screening
* 3.Blood purification twice or three times/week, including hemodialysis, hemofiltration, hemodiafiltration, CRRT or hybrid blood purification.
* 4.Regular hemodialysis≥1 month
* 5.Patients with arteriovenous fistula or artificial arteriovenous fistula.
* 6.Patients infected with Covid-19, the PCR CT value of nucleic acid detection\<35.
Exclusion Criteria:
* 1.Blood purification treatment\<1month.
* 2.Liver function (ALT or AST) is three times the upper the normal.
* 3.The severe or critical patients with Covid-19.
* 4.Drug that highly dependent on CYP3A, including but not limit to afzosin, pethidine, ranolazine, amiodarone, propafenone, quinidine, fusidic acid, voriconazole, terfenadine, colchicine, rifabutin, clozapine, dihydroergot, cisapride, simvastatin, diazepam, salbutam, triazolam, carbamazepine, phenobarbital, rifampicin.
* 5.Patients with galactose intolerance.
* 6\. Pregnant and lactating women.
* 7.Patients was allergic to paxlovid.
* 8.Participating in other intervention studies.
* 9.The investigator judged that the condition of the subjects was not suitable for the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05366192
Study Brief:
Protocol Section:
NCT05366192